MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm
MEMs-based Measurement and Classification System of Tremors in Parkinson Disease using MDS-UPDRS Scale as a Parameter

A. Delatorre, J. Marques (Florianópolis, Brazil)

Classification of Movement Disorders  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?

M. Hussein, A. Khamis, R. Soliman, S. Ali (Beni Suef, Egypt)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Microstructural Changes in Basal Ganglia and Cerebellar Networks in Patients with Idiopathic Blepharospasm

M. Esposito, T. Yousaf, H. Wilson, S. Peluso, L. Santoro, F. Manganelli, G. Pagano, M. Politis (Naples, Italy)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Modeling the Effect of Patient’s Perception of Non-Motor and Motor Function on Parkinson’s Disease Severity

C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)

Classification of Movement Disorders  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Modifiable factors and progression of motor symptoms and cognitive decline in Parkinson’s disease

E. Forbes, T. Tropea, S. Mantri, J. Morley (Philadelphia, PA, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Modulation of cerebellar and basal ganglia loops affects vestibular processing in Parkinson’s disease

J. Liao, C. Mcintyre, A. Shaikh (Cleveland, OH, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Monitoring Parkinson’s disease symptoms during daily life: A feasibility study

M. Heijmans, J. Habets, C. Herff, M. Kuijf, P. Kubben (Maastricht, Netherlands)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Motor and Non-Motor Symptom Burden in Parkinsonian and Cerebellar Phenotypes of Probable MSA

M R. Rukmani, R. Yadav, P K. Pal, B. Bhaskarapillai, T N. Sathyaprabha (Bangalore, India)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Motor and non-motor symptoms in the prediagnostic phase of progressive supranuclear palsy: the Step-Back PSP study.

C. Painous, C. Simonet, A. Garrido, N. Caballol, M. Guasp, A. Cámara, F. Valldeoriola, JE. Muñoz, MJ. Martí, Y. Compta (Barcelona, Catalonia)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Motor intracortical excitability before speech onset in adults who stutter

A. Elfers, S. Hommel, N. Neef, AW. von Gudenberg, W. Paulus, M. Sommer (Bad Emstal, Germany)

Neurophysiology  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 69
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley